Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches
Cyclosporine A (CsA) is one of the most effective systemic drugs available for the treatment of psoriasis, as evidenced by the results of several randomized studies and by a prolonged experience in dermatological setting. In clinical practice, CsA is usually used for the induction of psoriasis remis...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2013/805705 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568291066904576 |
|---|---|
| author | M. D. Colombo N. Cassano G. Bellia G. A. Vena |
| author_facet | M. D. Colombo N. Cassano G. Bellia G. A. Vena |
| author_sort | M. D. Colombo |
| collection | DOAJ |
| description | Cyclosporine A (CsA) is one of the most effective systemic drugs available for the treatment of psoriasis, as evidenced by the results of several randomized studies and by a prolonged experience in dermatological setting. In clinical practice, CsA is usually used for the induction of psoriasis remission at a daily dose included in the range of 2.5–5 mg/kg and with intermittent short-term regimens, lasting on average 3–6 months. The magnitude and rapidity of response are dose dependent, as well as the risk of development of adverse events. Therefore, the dose should be tailored to patient’s needs and general characteristics and adjusted during the treatment course according to both the efficacy and tolerability. Some studies support the feasibility of pulse administration of CsA for a few days per week for both the induction and the maintenance of response in psoriasis patients. This paper will review the data on CsA regimens for plaque-type psoriasis and will focus the attention on dose, treatment duration, novel schedules, and role in combination therapies, including the association with biologicals. |
| format | Article |
| id | doaj-art-62f6bf39499146c39f59fb61842c2851 |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-62f6bf39499146c39f59fb61842c28512025-02-03T00:59:24ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/805705805705Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment ApproachesM. D. Colombo0N. Cassano1G. Bellia2G. A. Vena3Novartis Farma S.p.A., Origgio, Varese, ItalyDermatology and Venereology Private Practice, Bari and Barletta, ItalyNovartis Farma S.p.A., Origgio, Varese, ItalyDermatology and Venereology Private Practice, Bari and Barletta, ItalyCyclosporine A (CsA) is one of the most effective systemic drugs available for the treatment of psoriasis, as evidenced by the results of several randomized studies and by a prolonged experience in dermatological setting. In clinical practice, CsA is usually used for the induction of psoriasis remission at a daily dose included in the range of 2.5–5 mg/kg and with intermittent short-term regimens, lasting on average 3–6 months. The magnitude and rapidity of response are dose dependent, as well as the risk of development of adverse events. Therefore, the dose should be tailored to patient’s needs and general characteristics and adjusted during the treatment course according to both the efficacy and tolerability. Some studies support the feasibility of pulse administration of CsA for a few days per week for both the induction and the maintenance of response in psoriasis patients. This paper will review the data on CsA regimens for plaque-type psoriasis and will focus the attention on dose, treatment duration, novel schedules, and role in combination therapies, including the association with biologicals.http://dx.doi.org/10.1155/2013/805705 |
| spellingShingle | M. D. Colombo N. Cassano G. Bellia G. A. Vena Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches The Scientific World Journal |
| title | Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches |
| title_full | Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches |
| title_fullStr | Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches |
| title_full_unstemmed | Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches |
| title_short | Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches |
| title_sort | cyclosporine regimens in plaque psoriasis an overview with special emphasis on dose duration and old and new treatment approaches |
| url | http://dx.doi.org/10.1155/2013/805705 |
| work_keys_str_mv | AT mdcolombo cyclosporineregimensinplaquepsoriasisanoverviewwithspecialemphasisondosedurationandoldandnewtreatmentapproaches AT ncassano cyclosporineregimensinplaquepsoriasisanoverviewwithspecialemphasisondosedurationandoldandnewtreatmentapproaches AT gbellia cyclosporineregimensinplaquepsoriasisanoverviewwithspecialemphasisondosedurationandoldandnewtreatmentapproaches AT gavena cyclosporineregimensinplaquepsoriasisanoverviewwithspecialemphasisondosedurationandoldandnewtreatmentapproaches |